ACIP Issues 2014 Immunization Schedule for Adults

Health Care Comments Off

Updated vaccination recommendations for adults aged 19 years and older for 2014 have been released by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization.

Haemophilus influenzae type b (Hib): The vaccine is recommended for certain adults at increased risk for Hib who have not received the vaccine before, except for those with HIV because their risk for Hib infection is low. Adults who have had a successful hematopoietic stem cell transplant are recommended to receive a 3–dose series of Hib vaccine 6 to 12 months after the transplant regardless of Hib vaccination status.
Influenza vaccine: The update adds information on the use of the recombinant influenza (RIV) and inactivated influenza (IIV) vaccines among egg–allergic patients was added to the footnote and indicates that RIV or IIV can be used among persons with hives-only allergy to eggs, as it contains no egg protein.
Td/Tdap: The tetanus, diphtheria, acellular pertussis (Tdap) and tetanus, diphtheria (Td) vaccines footnote was edited to harmonize with the language used in the pediatric immunization schedule. A single dose of Tdap vaccine is recommended for previously unvaccinated persons aged 11 years or older, and Td booster should be administered every 10 years thereafter.
Human papillomavirus: “Information was added to the human papillomavirus…vaccine footnote to clarify the timing between the second and third doses and to harmonize language between the pediatric and adult immunization schedules. No changes in recommendations were made.
Zoster: “Being a healthcare worker is no longer an indication for vaccination.”
Pneumococcal vaccines: “PCV13 (the 13–valent pneumococcal vaccine) is recommended to be administered before PPSV23 (the 23–valent pneumococcal vaccine) among persons for whom both vaccines are recommended. The PCV13 footnote now precedes the PPSV23 footnote and includes wording to remind providers of the appropriate order of these vaccines when both are indicated.”
Meningococcal vaccine: The footnote “was edited to clarify which persons need either one or two doses of vaccine and to provide greater clarity regarding which patients should receive meningococcal conjugate (MeanACWY–D) versus the meningococcal polysaccharide (MenACWY–CRM).”